The goal of this clinical trial is to promote lung cancer screening (LCS) uptake among
Hispanic current and former smokers. The main questions it aims to answer are:
- What barriers do current and former Hispanic smokers face in the identification and
documentation of their smoking status?
- How can digital delivery of an educational video promote LCS uptake among current
and former Hispanic smokers?
Participants will receive an educational video about lung cancer screening and complete
brief, self-reported surveys afterwards.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05784922.
Locations matching your search criteria
United States
Massachusetts
Charlestown
Massachusetts General HospitalStatus: Active
Contact: Efren Flores
Phone: 617-724-4254
Lung cancer remains the leading cause of cancer-specific mortality in the US, and
Hispanics experience worse lung cancer outcomes and die at higher rates due to advanced
stage at presentation. Lung cancer screening (LCS) can save many lives through early lung
cancer detection among Hispanic current and former smokers.
Still, without increasing efforts to improve smoking status disclosure and documentation
and tailored interventions to promote LCS uptake among Hispanic current and former
smokers, this underserved population will continue to demonstrate disparities in lung
cancer survival. Based on prior research experience, Dr. Flores has adapted the NIMHD
research framework by incorporating elements from Ford's evidence-based theoretical model
to guide the following proposed study aims:
1) To elucidate barriers and facilitators to consistent identification and documentation
of smoking status to promote LCS uptake among Hispanic current and former smokers; 2) To
assess feasibility, acceptability, and reach of the digital delivery of an educational
video to promote LCS uptake among Hispanic current and former smokers; 3) To explore the
effect of the digital delivery of the educational video to increase interest, intent, and
scheduling of LCS uptake among Hispanic current and former smokers.
Impact: The successful completion of this research will serve as a foundation for
developing novel interventions to overcome disparities and advance equity in lung cancer
outcomes among Hispanics and other vulnerable populations.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationMassachusetts General Hospital
Principal InvestigatorEfren Flores